Relief Cardiovascular is a privately held medical device company committed to improving outcomes for patients with heart failure. The company's flagship technology, the Relief System, is a transcatheter smart implant designed to enhance fluid management and improve quality of life for heart failure patients. Relief Cardiovascular was founded and incubated within inQB8 Medical Technologies, LLC.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
01/08/25 | $12,000,000 | Series A |
Advent Life Sciences Broadview Ventures Heartwork Capital Pacific Growth Investors | undisclosed |